Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wedo Capital, also known as Weidu Capital, is a specialized venture capital firm headquartered in Shanghai, China, that focuses exclusively on the healthcare and life sciences sectors. Founded in 2011, the firm targets early-stage and growth-stage companies across a broad spectrum of healthcare sub-sectors, including biotechnology, medical devices, in vitro diagnostics (IVD), and digital health services. Wedo Capital is known for its deep industry expertise and its ability to provide strategic value-add to its portfolio companies, helping them navigate clinical development, regulatory hurdles, and market entry in China. The firm's investment strategy is driven by a commitment to scientific innovation and the potential for significant clinical impact. By bridging the gap between laboratory research and commercialization, Wedo Capital plays a vital role in the growth of China's innovative healthcare ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wedo Capital.